BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26150529)

  • 1. Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties.
    Grishkan IV; Tosi DM; Bowman MD; Harary M; Calabresi PA; Gocke AR
    J Immunol; 2015 Aug; 195(4):1399-1407. PubMed ID: 26150529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis.
    Gocke AR; Lebson LA; Grishkan IV; Hu L; Nguyen HM; Whartenby KA; Chandy KG; Calabresi PA
    J Immunol; 2012 Jun; 188(12):5877-86. PubMed ID: 22581856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
    Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
    J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
    Carrier Y; Yuan J; Kuchroo VK; Weiner HL
    J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function.
    Pillemer BB; Xu H; Oriss TB; Qi Z; Ray A
    Eur J Immunol; 2007 Aug; 37(8):2082-9. PubMed ID: 17621372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
    Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
    J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells.
    Lalive PH; Benkhoucha M; Tran NL; Kreutzfeldt M; Merkler D; Santiago-Raber ML
    Eur J Immunol; 2014 Jan; 44(1):46-57. PubMed ID: 24018482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis.
    Huang YH; Tsai K; Ma C; Vallance BA; Priatel JJ; Tan R
    J Immunol; 2014 Dec; 193(12):5841-53. PubMed ID: 25362182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4
    Zhou F; Zhang GX; Rostami A
    Immunol Res; 2017 Jun; 65(3):630-638. PubMed ID: 27942984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
    Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
    Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
    Kavrochorianou N; Evangelidou M; Markogiannaki M; Tovey M; Thyphronitis G; Haralambous S
    J Leukoc Biol; 2016 Jan; 99(1):175-88. PubMed ID: 26232452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment.
    Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; Castañon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP
    Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th9 cells in the pathogenesis of EAE and multiple sclerosis.
    Elyaman W; Khoury SJ
    Semin Immunopathol; 2017 Jan; 39(1):79-87. PubMed ID: 27844107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo-induced self-antigen-specific Foxp3+ regulatory T cells impair the accumulation of inflammatory dendritic cells in draining lymph nodes.
    Alissafi T; Hatzioannou A; Ioannou M; Sparwasser T; Grün JR; Grützkau A; Verginis P
    J Immunol; 2015 Jun; 194(12):5812-24. PubMed ID: 25948818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.
    Bell CJ; Sun Y; Nowak UM; Clark J; Howlett S; Pekalski ML; Yang X; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Umana P; Klein C; Hosse RJ; Wicker LS; Peterson LB
    J Autoimmun; 2015 Jan; 56():66-80. PubMed ID: 25457307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice.
    Fernando V; Omura S; Sato F; Kawai E; Martinez NE; Elliott SF; Yoh K; Takahashi S; Tsunoda I
    Int J Mol Sci; 2014 Jan; 15(2):1700-18. PubMed ID: 24463292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel PADRE-Kv1.3 vaccine effectively induces therapeutic antibodies and ameliorates experimental autoimmune encephalomyelitis in rats.
    Fan C; Long R; You Y; Wang J; Yang X; Huang S; Sheng Y; Peng X; Liu H; Wang Z; Liu K
    Clin Immunol; 2018 Aug; 193():98-109. PubMed ID: 29496642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.